BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6276745)

  • 1. Defect in ACTH control after hypophysectomy in Cushing's disease.
    N Engl J Med; 1982 Mar; 306(11):679-80. PubMed ID: 6276745
    [No Abstract]   [Full Text] [Related]  

  • 2. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease.
    Lankford HV; Tucker HS; Blackard WG
    N Engl J Med; 1981 Nov; 305(21):1244-8. PubMed ID: 6270557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    Kasperlik-Zaluska AA; Jeske W
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):232. PubMed ID: 16060920
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
    Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
    [No Abstract]   [Full Text] [Related]  

  • 6. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
    Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
    Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyproheptadine in the control of Cushing's disease.
    Hsu TH; Gann DS; Tsan KW; Russell RP
    Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Cushing's disease: a hypothalamic flush?
    Feldman JM
    N Engl J Med; 1975 Oct; 293(18):930-1. PubMed ID: 170520
    [No Abstract]   [Full Text] [Related]  

  • 10. Source of ACTH in Cushing's disease.
    Wahl TO; Kyner JL
    N Engl J Med; 1979 Mar; 300(12):679. PubMed ID: 216916
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradoxical ACTH response to glucocorticoids in Cushing's disease.
    Fehm HL; Voight KH; Lang RE; Beinert KE; Kummer GW; Pfeiffer EF
    N Engl J Med; 1977 Oct; 297(17):904-7. PubMed ID: 198654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More on cyproheptadine in Cushing's disease.
    N Engl J Med; 1977 Mar; 296(10):576-7. PubMed ID: 189191
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective venous sampling to differentiate ectopic ACTH secretion from pituitary Cushing's syndrome.
    Corrigan DF; Schaaf M; Whaley RA; Czerwinski CL; Earll JM
    N Engl J Med; 1977 Apr; 296(15):861-2. PubMed ID: 191749
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ketoconazole on CRH-induced ACTH and cortisol release in patients with Cushing's disease.
    Berselli ME; Tagliaferri M; Vignati F; Loli P
    Horm Metab Res Suppl; 1987; 16():58-9. PubMed ID: 2832290
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of cyproheptadine in the treatment of Cushing's disease].
    Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
    Clin Ter; 1979 Feb; 88(4):345-54. PubMed ID: 222530
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.
    Ishibashi M; Yamaji T
    J Clin Invest; 1981 Oct; 68(4):1018-27. PubMed ID: 6270192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
    Zgliczyński S; Kozłowicz I; Wilczyńska J; Baranowska B
    Mater Med Pol; 1980; 12(1-2):85-90. PubMed ID: 6276625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of Cushing's syndrome].
    Labhart A
    Dtsch Med Wochenschr; 1969 Jan; 94(1):36-7. PubMed ID: 4302213
    [No Abstract]   [Full Text] [Related]  

  • 20. Cushing's disease cycling over ten years.
    Popovic V; Micic D; Nesovic M; Howlett T; Doniach I; Kendereski A; Djordjevic P; Manojlovic D; Micic J; Besser M
    Exp Clin Endocrinol; 1990 Nov; 96(2):143-8. PubMed ID: 1965804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.